The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Abstract
Purpose: Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual survival of the patient with cancer. The purpose of this effort was to develop recommendations for prevention and monitoring of cardiac dysfunction in survivors of adult-onset cancers. Methods: Recommendations were developed by an expert panel with multidisciplinary representation using a systematic review (1996 to 2016) of meta-analyses, randomized clinical trials, observational studies, and clinical experience. Study quality was assessed using established methods, per study design. The guideline recommendations were crafted in part using the Guidelines Into Decision Support methodology. Results: A total of 104 studies met eligibility criteria and compose the evidentiary basis for the recommendations. The strength of the recommendations in these guidelines is based on the quality, amount, and consistency of the evidence and the balance between benefits and harms. Recommendations: It is important for health care providers to initiate the discussion regarding the potential for cardiac dysfunction in individuals in whom the risk is sufficiently high before beginning therapy. Certain higher risk populations of survivors of cancer may benefit from prevention and screening strategies implemented during cancer-directed therapies. Clinical suspicion for cardiac disease should be high and threshold for cardiac evaluation should be low in any survivor who has received potentially cardiotoxic therapy. For certain higher risk survivors of cancer, routine surveillance with cardiac imaging may be warranted after completion of cancer-directed therapy, so that appropriate interventions can be initiated to halt or even reverse the progression of cardiac dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Self-citationAdjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Self-citationBreast cancer statistics, 2013
DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,143
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Self-citationEarly Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Voigt, J.-U., Pedrizzetti, G., Lysyansky, P., Marwick, T. H., Houle, H., Baumann, R., Pedri, S., Ito, Y., Abe, Y., Metz, S., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.11.003 · Cited by 1,580
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
Seidman, A. D., Hudis, C. A., Pierri, M. K., Shak, S., Paton, V. E., Ashby, M. A., Murphy, M., Stewart, S. J., & Keefe, D. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1215 · Cited by 1,563
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationAnthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Thavendiranathan, P., Poulin, F., Lim, K.-D., Plana, J. C., Woo, A., & Marwick, T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.073 · Cited by 1,079
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Cardinale, D., Sandri, M. T., Colombo, A., Colombo, N., Boeri, M., Lamantia, G., Civelli, M., Peccatori, F., Martinelli, G., Fiorentini, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130926.51766.cc · Cited by 955
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000067 · Cited by 928
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
Hooning, M. J., Botma, A., Aleman, B. M. P., Baaijens, M. H. A., Bartelink, H., Klijn, J. G. M., Taylor, C. W., & van Leeuwen, F. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk064 · Cited by 861
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., Cohen, V., Banchs, J., Carver, J. R., Wiegers, S. E., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.973321 · Cited by 814
Self-citationTan-Chiu, E., Yothers, G., Romond, E., Geyer, C. E., Ewer, M., Keefe, D., Shannon, R. P., Swain, S. M., Brown, A., Fehrenbacher, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4091 · Cited by 808
Self-citationSmith, L. A., Cornelius, V. R., Plummer, C. J., Levitt, G., Verrill, M., Canney, P., & Jones, A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-337 · Cited by 753
Late cardiotoxicity after treatment for Hodgkin lymphoma
Aleman, B. M. P., van den Belt-Dusebout, A. W., De Bruin, M. L., van 't Veer, M. B., Baaijens, M. H. A., Boer, J. P. D., Hart, A. A. M., Klokman, W. J., Kuenen, M. A., Ouwens, G. M., et al. (2007) · Blood · doi:10.1182/blood-2006-07-034405 · Cited by 746
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Thavendiranathan, P., Grant, A. D., Negishi, T., Plana, J. C., Popović, Z. B., & Marwick, T. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.035 · Cited by 689
Gulati, G., Heck, S. L., Ree, A. H., Hoffmann, P., Schulz-Menger, J., Fagerland, M. W., Gravdehaug, B., von Knobelsdorff-Brenkenhoff, F., Bratland, Å., Storås, T. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw022 · Cited by 687
Northfelt, D. W., Dezube, B. J., Thommes, J. A., Miller, B. J., Fischl, M. A., Friedman-Kien, A., Kaplan, L. D., Du Mond, C., Mamelok, R. D., & Henry, D. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2445 · Cited by 649
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Cardinale, D., Colombo, A., Torrisi, R., Sandri, M. T., Civelli, M., Salvatici, M., Lamantia, G., Colombo, N., Cortinovis, S., Dessanai, M. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3615 · Cited by 641
Pinder, M. C., Duan, Z., Goodwin, J. S., Hortobagyi, G. N., & Giordano, S. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4976 · Cited by 634
Bosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Schmidinger, M., Zielinski, C. C., Vogl, U. M., Bojic, A., Bojic, M., Schukro, C., Ruhsam, M., Hejna, M., & Schmidinger, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6331 · Cited by 615
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Self-citationArmenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70409-7 · Cited by 570
Self-citationBowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A. B., Davis, R. L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs317 · Cited by 566
Ky, B., Putt, M., Sawaya, H., French, B., Januzzi, J. L., Sebag, I. A., Plana, J. C., Cohen, V., Banchs, J., Carver, J. R., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.061 · Cited by 563
Self-citationArmenian, S. H., Xu, L., Ky, B., Sun, C., Farol, L. T., Pal, S. K., Douglas, P. S., Bhatia, S., & Chao, C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0409 · Cited by 559
Self-citationPerez, E. A., Suman, V. J., Davidson, N. E., Sledge, G. W., Kaufman, P. A., Hudis, C. A., Martino, S., Gralow, J. R., Dakhil, S. R., Ingle, J. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5467 · Cited by 538
Romond, E. H., Jeong, J.-H., Rastogi, P., Swain, S. M., Geyer, C. E., Ewer, M. S., Rathi, V., Fehrenbacher, L., Brufsky, A., Azar, C. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.0010 · Cited by 520
Self-citationCardiovascular Disease After Hodgkin Lymphoma Treatment: 40-Year Disease Risk
van Nimwegen, F. A., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., Petersen, E. J., Raemaekers, J. M. M., Kok, W. E. M., Aleman, B. M. P., & van Leeuwen, F. E. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1180 · Cited by 514
Fallah-Rad, N., Walker, J. R., Wassef, A., Lytwyn, M., Bohonis, S., Fang, T., Tian, G., Kirkpatrick, I. D. C., Singal, P. K., Krahn, M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.063 · Cited by 484
van Nimwegen, F. A., Schaapveld, M., Cutter, D. J., Janus, C. P. M., Krol, A. D. G., Hauptmann, M., Kooijman, K., Roesink, J., van der Maazen, R., Darby, S. C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4444 · Cited by 464
Negishi, K., Negishi, T., Hare, J. L., Haluska, B. A., Plana, J. C., & Marwick, T. H. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.02.008 · Cited by 454
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemagi, C. M. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 432
Harris, E. E. R., Correa, C., Hwang, W.-T., Liao, J., Litt, H. I., Ferrari, V. A., & Solin, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1037 · Cited by 393
Hershman, D. L., McBride, R. B., Eisenberger, A., Tsai, W. Y., Grann, V. R., & Jacobson, J. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1242 · Cited by 390
Viani, G. A., Afonso, S. L., Stefano, E. J., De Fendi, L. I., & Soares, F. V. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-153 · Cited by 381
Guarneri, V., Lenihan, D. J., Valero, V., Durand, J.-B., Broglio, K., Hess, K. R., Michaud, L. B., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Esteva, F. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9551 · Cited by 361
Self-citationIncidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
Chen, J., Long, J. B., Hurria, A., Owusu, C., Steingart, R. M., & Gross, C. P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.068 · Cited by 352
Kalam, K., & Marwick, T. H. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.030 · Cited by 343
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults
Hequet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., Dumontet, C., Thieblemont, C., Arnaud, P., Antal, D., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.033 · Cited by 340
Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based Study
Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5841 · Cited by 335
Polk, A., Vaage-Nilsen, M., Vistisen, K., & Nielsen, D. L. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.005 · Cited by 329
Kaya, M. G., Ozkan, M., Gunebakmaz, O., Akkaya, H., Kaya, E. G., Akpek, M., Kalay, N., Dikilitas, M., Yarlioglues, M., Karaca, H., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.023 · Cited by 325
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
Speyer, J. L., Green, M. D., Zeleniuch-Jacquotte, A., Wernz, J. C., Rey, M., Sanger, J., Kramer, E., Ferrans, V, Hochster, H., & Meyers, M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.117 · Cited by 322
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Borghini, E., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Fiorentini, C., & Cipolla, C. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf170 · Cited by 313
Patt, D. A., & Giordano, S. H. (2007) · Breast Diseases: A Year Book Quarterly · doi:10.1016/s1043-321x(07)80352-3 · Cited by 305
Rafiyath, S. M., Rasul, M., Lee, B., Wei, G., Lamba, G., & Liu, D. (2012) · Experimental Hematology & Oncology · doi:10.1186/2162-3619-1-10 · Cited by 302
Sandri, M. T., Salvatici, M., Cardinale, D., Zorzino, L., Passerini, R., Lentati, P., Leon, M., Civelli, M., Martinelli, G., & Cipolla, C. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050153 · Cited by 250
Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer
Chavez-MacGregor, M., Zhang, N., Buchholz, T. A., Zhang, Y., Niu, J., Elting, L., Smith, B. D., Hortobagyi, G. N., & Giordano, S. H. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.7884 · Cited by 244
Procter, M., Suter, T. M., de Azambuja, E., Dafni, U., van Dooren, V., Muehlbauer, S., Climent, M. A., Rechberger, E., Liu, W. T.-W., Toi, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0463 · Cited by 244
Ho, E., Brown, A., Barrett, P., Morgan, R. B., King, G., Kennedy, M. J., & Murphy, R. T. (2010) · Heart · doi:10.1136/hrt.2009.173997 · Cited by 242
(2008) · Cited by 225
Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
Neilan, T. G., Coelho-Filho, O. R., Pena-Herrera, D., Shah, R. V., Jerosch-Herold, M., Francis, S. A., Moslehi, J., & Kwong, R. Y. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.07.040 · Cited by 224
Self-citationChow, E. J., Mueller, B. A., Baker, K. S., Cushing-Haugen, K. L., Flowers, M. E. D., Martin, P. J., Friedman, D. L., & Lee, S. J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-1-201107050-00004 · Cited by 215
Di Lorenzo, G., Autorino, R., Bruni, G., Cartenì, G., Ricevuto, E., Tudini, M., Ficorella, C., Romano, C., Aieta, M., Giordano, A., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp025 · Cited by 207
Self-citationMeinardi, M. T., van Veldhuisen, D. J., Gietema, J. A., Dolsma, W. V., Boomsma, F., van den Berg, M. P., Volkers, C., Haaksma, J., de Vries, E. G. E., Sleijfer, D. T., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2746 · Cited by 207
Marty, M., Espié, M., Llombart, A., Monnier, A., Rapoport, B. L., & Stahalova, V. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj134 · Cited by 202
Boekhout, A. H., Gietema, J. A., Milojkovic Kerklaan, B., van Werkhoven, E. D., Altena, R., Honkoop, A., Los, M., Smit, W. M., Nieboer, P., Smorenburg, C. H., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1726 · Cited by 201
Dodos, F., Halbsguth, T., Erdmann, E., & Hoppe, U. C. (2008) · Clinical Research in Cardiology · doi:10.1007/s00392-007-0633-6 · Cited by 174
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma
Moser, E. C. (2006) · Blood · doi:10.1182/blood-2005-08-3392 · Cited by 174
Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial
Advani, P. P., Ballman, K. V., Dockter, T. J., Colon-Otero, G., & Perez, E. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.8413 · Cited by 171
Maraldo, M. V., Giusti, F., Vogelius, I. R., Lundemann, M., van der Kaaij, M. A. E., Ramadan, S., Meulemans, B., Henry-Amar, M., Aleman, B. M. P., Raemaekers, J., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00153-2 · Cited by 169
cTnT can be a useful marker for early detection of anthracycline cardiotoxicity
Kilickap, S., Barista, I., Akgul, E., Aytemir, K., Aksoyek, S., Aksoy, S., Celik, I., Kes, S., & Tekuzman, G. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi152 · Cited by 167
Chan, S. Y. T., Davidson, N. G. P., Juozaitytė, E., Erdkamp, F., Pluzanska, A., Azarnia, N., & Lee, L. W. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh393 · Cited by 167
Venturini, M., Michelotti, A., Del Mastro, L., Gallo, L., Carnino, F., Garrone, O., Tibaldi, C., Molea, N., Bellina, R. C., Pronzato, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3112 · Cited by 165
Seicean, S., Seicean, A., Alan, N., Plana, J. C., Budd, G. T., & Marwick, T. H. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000055 · Cited by 165
Armenian, S. H., Sun, C.-L., Shannon, T., Mills, G., Francisco, L., Venkataraman, K., Wong, F. L., Forman, S. J., & Bhatia, S. (2011) · Blood · doi:10.1182/blood-2011-06-358226 · Cited by 164
Self-citationThavendiranathan, P., Wintersperger, B. J., Flamm, S. D., & Marwick, T. H. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.000899 · Cited by 163
Swain, S. M., Ewer, M. S., Cortés, J., Amadori, D., Miles, D., Knott, A., Clark, E., Benyunes, M. C., Ross, G., & Baselga, J. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0448 · Cited by 163
Self-citationCasper, E. S., Gaynor, J. J., Hajdu, S. I., Magill, G. B., Tan, C., Friedrich, C., & Brennan, M. F. (1991) · Cancer · doi:10.1002/1097-0142(19910915)68:6<1221::aid-cncr2820680607>3.0.co;2-r · Cited by 161
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
Serrano, C., Cortés, J., De Mattos-Arruda, L., Bellet, M., Gómez, P., Saura, C., Pérez, J., Vidal, M., Muñoz-Couselo, E., Carreras, M. J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr348 · Cited by 161
Cadeddu, C., Piras, A., Mantovani, G., Deidda, M., Dessì, M., Madeddu, C., Massa, E., & Mercuro, G. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.05.037 · Cited by 159
Slamon, D., EIERMANN, W., Robert, N., Giermek, J., Martín, M., Jasiówka, M., Mackey, J., Chan, A., Liu, M.-C., Pintér, T., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.sabcs15-s5-04 · Cited by 154
Late Congestive Heart Failure After Hematopoietic Cell Transplantation
Armenian, S. H., Sun, C., Francisco, L., Steinberger, J., Kurian, S., Wong, F. L., Sharp, J., Sposto, R., Forman, S. J., & Bhatia, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7428 · Cited by 150
Self-citationMorris, P. G., Chen, C. C. L., Steingart, R. M., Fleisher, M., Lin, N., Moy, B., Come, S. E., Sugarman, S. M., Abbruzzi, A., Lehman, R. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1359 · Cited by 143
López, M., Vici, P., Lauro, K. D., Conti, F., Paoletti, G., Ferraironi, A., Sciuto, R., Giannarelli, D., & MAINI, C. L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.86 · Cited by 140
Daugaard, G., Lassen, U., Bie, P., et al. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.009 · Cited by 139
Jones, S. E., Collea, R., Paul, D., SEDLACEK, S. M., Favret, A. M., Gore, I., Lindquist, D. L., Holmes, F. A., Allison, M. A. K., Brooks, B. D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70384-x · Cited by 136
Onitilo, A. A., Engel, J. M., Stankowski, R. V., Liang, H., Berg, R. L., & Doi, S. A. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2039-z · Cited by 133
Early cardiotoxicity of the CHOP regimen in aggressivenon-Hodgkin’s lymphoma
Limat, S., Demesmay, K., Voillat, L., Bernard, Y. F., Deconinck, É., Brion, A., Rebibo-Sabbah, A., Woronoff-Lemsi, M. C., & Cahn, J.-Y. Y. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg070 · Cited by 133
Rifkin, R. M., Gregory, S. A., Mohrbacher, A. M., & Hussein, M. A. (2006) · Cancer · doi:10.1002/cncr.21662 · Cited by 130
Bellinger, A. M., Arteaga, C. L., Force, T. L., Humphreys, B. D., Demetri, G. D., Druker, B. J., & Moslehi, J. J. (2015) · Circulation · doi:10.1161/circulationaha.115.010484 · Cited by 125
Self-citationChow, E. J., Baker, K. S., Lee, S. J., Flowers, M. E. D., Cushing‐Haugen, K. L., Inamoto, Y., Khera, N., Leisenring, W. M., Syrjala, K. L., & Martin, P. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6582 · Cited by 117
Farolfi, A., Melegari, E., Aquilina, M., Scarpi, E., Ibrahim, T., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Ferrario, C., et al. (2013) · Heart · doi:10.1136/heartjnl-2012-303151 · Cited by 112
Petersen, P. M., Aznar, M. C., Berthelsen, A. K., Loft, A., Schut, D. A., Maraldo, M. V., Josipović, M., Klausen, T. L., Andersen, F. L., & Specht, L. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.932435 · Cited by 109
Fumoleau, P., Roche, H. H., Kerbrat, P., Bonneterre, J. M., Romestaing, P., Fargeot, P., Namer, M., Monnier, A., Montcuquet, P., Goudier, M.-J., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj034 · Cited by 109
Brain Natriuretic Peptide Is a Predictor of Anthracycline-Induced Cardiotoxicity
Okumura, H., Iuchi, K., Yoshida, T., Nakamura, S., Takeshima, M., Takamatsu, H., Ikeno, A., Usuda, K., Ishikawa, T., Ohtake, S., et al. (2000) · Acta Haematologica · doi:10.1159/000046508 · Cited by 108
The State of Cancer Care in America, 2015: A Report by the American Society of Clinical Oncology
American Society of Clinical Oncology (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.003772 · Cited by 103
Early Detection of Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer
Florescu, M., Magda, S. L., Enescu, O. A., Jinga, D. C., & Vinereanu, D. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.10.008 · Cited by 100
Response of Doxorubicin-induced Cardiomyopathy to the Current Management Strategy of Heart Failure
Tallaj, J. A., Franco, V., Rayburn, B. K., Pinderski, L. J., Benza, R. L., Pamboukian, S. V., Foley, B. A., & Bourge, R. C. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.12.108 · Cited by 100
Maraldo, M. V., Brodin, N. P., Vogelius, I. R., Aznar, M. C., af Rosenschöld, P. M., Petersen, R. H., & Specht, L. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.09.020 · Cited by 99
Civelli, M., Cardinale, D. M., Martinoni, A., Lamantia, G., Colombo, N., Colombo, A., Gandini, S., Martinelli, G., Fiorentini, C., & Cipolla, C. M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.07.029 · Cited by 90
Dang, C. T., Guo, H., Najita, J., Yardley, D. A., Marcom, K., Albain, K. S., Rugo, H. S., Miller, K. D., Ellis, M. J., Shapira, I., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3709 · Cited by 90
Self-citationPituskin, E., Haykowsky, M. J., Mackey, J. R., Thompson, R. B., Ezekowitz, J. A., Koshman, S. L., Oudit, G. Y., Chow, K., Pagano, J. J., & Paterson, D. I. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-318 · Cited by 89
A Comparative Study of Doxorubicin and Epirubicin in Patients with Metastatic Breast Cancer
Hortobágyi, G. N., Yap, H. Y., Kau, S., Fraschini, G., Ewer, M. S., Chawla, S. P., & Benjamin, R. S. (1989) · American Journal of Clinical Oncology · doi:10.1097/00000421-198902000-00014 · Cited by 88
Self-citationGanz, P. A., Hussey, M. A., Moinpour, C. M., Unger, J. M., Hutchins, L. F., Dakhil, S. R., Giguere, J. K., Goodwin, J. W., Martino, S., & Albain, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8877 · Cited by 85
Stoodley, P. W., Richards, D. A. B., Boyd, A. C., Hui, R., Harnett, P. R., Meikle, S. R., Clarke, J., & Thomas, L. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes139 · Cited by 81
Brockstein, B., Smiley, C. M., Al‐Sadir, J., & Williams, S. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702234 · Cited by 79
Goldhar, H. A., Yan, A. T.-K., Ko, D. T., Earle, C. C., TOMLINSON, G. A., Trudeau, M., Krahn, M. D., Krzyzanowska, M. K., Pal, R., Brezden‐Masley, C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv301 · Cited by 75
Stoodley, P. W., Richards, D. A., Boyd, A. C., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.046 · Cited by 72
Pichon, M.-F., Cvitkovic, F., Hacène, K., Delaunay, J., Lokiec, F. M., Collignon, M. A., & Pecking, A. P. (2005) · PubMed · Cited by 71
Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy
Motoki, H., Koyama, J., Nakazawa, H., Aizawa, K., Kasai, H., Izawa, A., Tomita, T., Miyashita, Y., Kumazaki, S., Takahashi, M., et al. (2011) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ejechocard/jer172 · Cited by 68
Tarantini, L., Gori, S., Faggiano, P. M., Pulignano, G., Simoncini, E., Tuccia, F., Ceccherini, R., Bovelli, D., Lestuzzi, C., & Cioffi, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds127 · Cited by 66
Perik, P. J., Rikhof, B., de Jong, F. A., Verweij, J., Gietema, J. A., & van der Graaf, W. T. A. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm468 · Cited by 62
Monitoring Left Ventricular Function in Adults Receiving Anthracycline-Containing Chemotherapy
Belham, M., Kruger, A. R., Mepham, S., Faganello, G., & Pritchard, C. W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.09.007 · Cited by 60
Ibrahim, N. K., Hortobágyi, G. N., Ewer, M. S., Ali, M. K., Asmar, L., Theriault, R. L., Fraschini, G., Frye, D. K., & Buzdar, A. U. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050926 · Cited by 58
Self-citationDu, X. L., Xia, R., Burau, K. D., & Liu, C. (2010) · Medical Oncology · doi:10.1007/s12032-010-9717-7 · Cited by 56
Murbræch, K., Smeland, K. B., Holte, H., Loge, J. H., Lund, M. B., Wethal, T., Holte, E., Rösner, A., Dalen, H., Kvaløy, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.8125 · Cited by 56
Avilés, A., Neri, N., Nambo, M. J., et al. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500063229 · Cited by 55
Mantovani, G., Madeddu, C., Dessalvi, C. C., Dessì, M., Piras, A., Massa, E., Serpe, R., Antoni, G., & Mercuro, G. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0151 · Cited by 44
Charpentier, A.-M., Conrad, T., Sykes, J. R., Ng, A., Zhou, R., Parent, A. L., Coolens, C., Tsang, R. W. C., Gospodarowicz, M. K., Sun, A. Y., et al. (2013) · Practical Radiation Oncology · doi:10.1016/j.prro.2013.07.015 · Cited by 43
Éderhy, S., Massard, C., Dufaître, G., Balheda, R., Meuleman, C., Gomez‐Roca, C., Izzedine, H., Cohen, A. A., & Soria, J. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9546-8 · Cited by 41
Cao, L., Hu, W., Kirova, Y., Yang, Z., Cai, G., Yu, X., Ma, J. L., Guo, X., Shao, Z., & Chen, J. (2014) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2014.01.001 · Cited by 30
Hilbers, F., Boekel, N. B., van den Broek, A. J., van Hien, R., Cornelissen, S., Aleman, B. M. P., Veer, L. V. ‘., van Leeuwen, F. E., & Schmidt, M. K. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.10.017 · Cited by 28
Cited by
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
Cancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Self-citationMyocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Self-citationThe Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Metadata
- Authors
- Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., Fabian, C., Hudson, M., Jessup, M., Jones, L. W., Ky, B., Mayer, E. L., Moslehi, J., Oeffinger, K., Ray, K., Ruddy, K., & Lenihan, D.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-03-10
- Volume
- 35
- Issue
- 8
- Pages
- 893-911
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2560560709
- Cited by
- 1,290
- References
- 126
- FWCI
- 75.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.